Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2score ⩾ 2-Reference-Cited by-同舟云学术

Systematic review and network meta-analysis of the relative efficacy and safety of edoxaban versus other nonvitamin K antagonist oral anticoagulants among patients with nonvalvular atrial fibrillation and CHADS2score ⩾ 2

Published:2015-10-27 Issue: Volume:3 Page:205031211561335
ISSN:2050-3121
Container-title:SAGE Open Medicine
language:en
Short-container-title:SAGE Open Medicine

Author:

Fernandez Maria M¹,Wang Jianmin¹,Ye Xin²,Kwong Winghan Jacqueline²,Sherif Bintu¹,Hogue Susan¹,Sherrill Beth¹

Affiliation:

1. RTI Health Solutions, Durham, NC, USA

2. Daiichi Sankyo, Inc., Parsippany, NJ, USA

Publisher

SAGE Publications

Subject

General Medicine

Link

http://journals.sagepub.com/doi/pdf/10.1177/2050312115613350

Reference34 articles.

1. The Epidemiology of Atrial Fibrillation in Elderly Persons: The Tip of the Iceberg

2. Clinical, Economic, and Quality of Life Impact of Atrial Fibrillation

3. Validation of Clinical Classification Schemes for Predicting Stroke

4. Improving Stroke Risk Stratification in Atrial Fibrillation

5. 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: Executive Summary

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of DOACs in frail elderly patients in light of class genericization;International Journal of Cardiology;2024-09

2. Use of Doacs in Frail Elderly Patients in Light of Class Genericization;2024

3. Safety outcomes of direct oral anticoagulants in older adults with atrial fibrillation: a systematic review and meta-analysis of (subgroup analyses from) randomized controlled trials;GeroScience;2023-06-01

4. Stroke Prevention in Atrial Fibrillation;Trends in Cardiovascular Medicine;2021-10

5. Ten years of non-vitamin K antagonists oral anticoagulants for stroke prevention in atrial fibrillation: is warfarin obsolete?;European Heart Journal Supplements;2020-12